Skip to main content
. 2024 Oct 31;12(11):1241. doi: 10.3390/vaccines12111241

Figure 1.

Figure 1

Systemic and neutralizing immune responses against wild-type SARS-CoV-2 (WT) and omicron subvariants induced by XBB.1.5 COVID-19 vaccines. (a) Serum levels of anti-RBD IgG before (pre) and two to four weeks after (post) vaccination. (b) Stratification of anti-RBD IgG levels two to four weeks after vaccination by virus variant. (c) Serum-mediated ACE2 binding inhibition before (pre) and two to four weeks after (post) vaccination. (d) Stratification of ACE2 binding inhibition two to four weeks after vaccination by virus variant. Crossbars indicate medians and statistical analyses are based on exact Wilcoxon signed-rank tests (a,c) or Friedman tests (b,d).